OBJECTIVE: Guidelines recommend risk-reduction counseling by HIV providers to all HIV-infected persons. Among HIV-infected adults receiving medical care in the United States, we estimated prevalence of exposure to three types of HIV/sexually transmitted disease (STD) risk-reduction interventions and described the characteristics of persons who received these interventions. DESIGN: Data were from the Medical Monitoring Project (MMP), a supplemental HIV surveillance system designed to produce nationally representative estimates of behavioral and clinical characteristics of HIV-infected adults receiving medical care in the United States. METHODS: Descriptive analyses were conducted to estimate the exposure to each type of HIV/STD risk-reduction intervention. Bivariate and multivariable analyses were conducted to assess associations between the selected correlates with each exposure variable. RESULTS: About 44% of participants reported a one-on-one conversation with a healthcare provider about HIV/STD prevention, 30% with a prevention program worker, 16% reported participation in a small group risk-reduction intervention, and 52% reported receiving at least one of the three interventions in the past 12 months. Minority race/ethnicity, low income, and risky sexual behavior consistently predicted greater intervention exposure. However, 39% of persons who reported risky sex did not receive any HIV/STD risk-reduction interventions. CONCLUSIONS: HIV-infected persons in care with fewer resources or those who engaged in risk behaviors were more likely to receive HIV/STD risk-reduction interventions. However, less than half of HIV-infected persons in care received HIV/STD prevention counseling from their provider, an intervention that has been shown to be effective and is supported by guidelines.
OBJECTIVE: Guidelines recommend risk-reduction counseling by HIV providers to all HIV-infectedpersons. Among HIV-infected adults receiving medical care in the United States, we estimated prevalence of exposure to three types of HIV/sexually transmitted disease (STD) risk-reduction interventions and described the characteristics of persons who received these interventions. DESIGN: Data were from the Medical Monitoring Project (MMP), a supplemental HIV surveillance system designed to produce nationally representative estimates of behavioral and clinical characteristics of HIV-infected adults receiving medical care in the United States. METHODS: Descriptive analyses were conducted to estimate the exposure to each type of HIV/STD risk-reduction intervention. Bivariate and multivariable analyses were conducted to assess associations between the selected correlates with each exposure variable. RESULTS: About 44% of participants reported a one-on-one conversation with a healthcare provider about HIV/STD prevention, 30% with a prevention program worker, 16% reported participation in a small group risk-reduction intervention, and 52% reported receiving at least one of the three interventions in the past 12 months. Minority race/ethnicity, low income, and risky sexual behavior consistently predicted greater intervention exposure. However, 39% of persons who reported risky sex did not receive any HIV/STD risk-reduction interventions. CONCLUSIONS:HIV-infectedpersons in care with fewer resources or those who engaged in risk behaviors were more likely to receive HIV/STD risk-reduction interventions. However, less than half of HIV-infectedpersons in care received HIV/STD prevention counseling from their provider, an intervention that has been shown to be effective and is supported by guidelines.
Authors: Jeffrey D Fisher; William A Fisher; Deborah H Cornman; Rivet K Amico; Angela Bryan; Gerald H Friedland Journal: J Acquir Immune Defic Syndr Date: 2006-01-01 Impact factor: 3.731
Authors: Janet J Myers; Mi-Suk Kang Dufour; Kimberly A Koester; Carol Dawson Rose; Starley B Shade; Andres Maiorana; Stephen F Morin Journal: AIDS Care Date: 2012-09-13
Authors: J Bluespruce; W T Dodge; L Grothaus; K Wheeler; V Rebolledo; J W Carey; T A McAfee; R S Thompson Journal: AIDS Patient Care STDS Date: 2001-05 Impact factor: 5.078
Authors: Blair T Johnson; Michael P Carey; Stephenie R Chaudoir; Allecia E Reid Journal: J Acquir Immune Defic Syndr Date: 2006-04-15 Impact factor: 3.731
Authors: Judith A Aberg; Jonathan E Kaplan; Howard Libman; Patricia Emmanuel; Jean R Anderson; Valerie E Stone; James M Oleske; Judith S Currier; Joel E Gallant Journal: Clin Infect Dis Date: 2009-09-01 Impact factor: 9.079
Authors: Mark Thrun; Paul F Cook; Lucy A Bradley-Springer; Lytt Gardner; Gary Marks; Julie Wright; Tracey E Wilson; E Byrd Quinlivan; Christine O'Daniels; Stephen Raffanti; Melanie Thompson; Carol Golin Journal: AIDS Educ Prev Date: 2009-02
Authors: Martin R Frankel; Ad McNaghten; Martin F Shapiro; Patrick S Sullivan; Sandra H Berry; Christopher H Johnson; Elaine W Flagg; Sally Morton; Samuel A Bozzette Journal: Open AIDS J Date: 2012-09-07
Authors: Alex de Voux; Kyle T Bernstein; Heather Bradley; Robert D Kirkcaldy; Yunfeng Tie; R Luke Shouse Journal: Clin Infect Dis Date: 2019-03-05 Impact factor: 9.079
Authors: Derek T Dangerfield; Allison J Ober; Janeane N Anderson; Pamina Gorbach; Ricky N Bluthenthal Journal: Public Health Nurs Date: 2021-08-17 Impact factor: 1.462
Authors: Kathy K Byrd; Felicia Hardnett; Patrick G Clay; Ambrose Delpino; Ron Hazen; Michael D Shankle; Nasima M Camp; Sumihiro Suzuki; Paul J Weidle Journal: AIDS Patient Care STDS Date: 2019-01-16 Impact factor: 5.078
Authors: Elaine W Flagg; Hillard S Weinstock; Emma L Frazier; Eduardo E Valverde; James D Heffelfinger; Jacek Skarbinski Journal: Sex Transm Dis Date: 2015-04 Impact factor: 2.830
Authors: Michael Costa; Brian T Montague; Liza Solomon; Cara Sammartino; Roee Gutman; Chava Zibman; David Rosen; Josiah D Rich Journal: J Urban Health Date: 2018-08 Impact factor: 3.671